Elena Tirrò

2.0k total citations
48 papers, 1.0k citations indexed

About

Elena Tirrò is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Elena Tirrò has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 25 papers in Hematology and 10 papers in Molecular Biology. Recurrent topics in Elena Tirrò's work include Chronic Myeloid Leukemia Treatments (25 papers), Chronic Lymphocytic Leukemia Research (18 papers) and Eosinophilic Disorders and Syndromes (8 papers). Elena Tirrò is often cited by papers focused on Chronic Myeloid Leukemia Treatments (25 papers), Chronic Lymphocytic Leukemia Research (18 papers) and Eosinophilic Disorders and Syndromes (8 papers). Elena Tirrò collaborates with scholars based in Italy, United Kingdom and United States. Elena Tirrò's co-authors include Livia Manzella, Michele Massimino, Paolo Vigneri, Stefania Stella, Chiara Romano, Maria Stella Pennisi, Adriana Puma, Silvia Rita Vitale, Francesco Di Raimondo and Fabio Stagno and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Elena Tirrò

46 papers receiving 1.0k citations

Peers

Elena Tirrò
Elena Tirrò
Citations per year, relative to Elena Tirrò Elena Tirrò (= 1×) peers Michele Massimino

Countries citing papers authored by Elena Tirrò

Since Specialization
Citations

This map shows the geographic impact of Elena Tirrò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Tirrò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Tirrò more than expected).

Fields of papers citing papers by Elena Tirrò

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Tirrò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Tirrò. The network helps show where Elena Tirrò may publish in the future.

Co-authorship network of co-authors of Elena Tirrò

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Tirrò. A scholar is included among the top collaborators of Elena Tirrò based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Tirrò. Elena Tirrò is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pennisi, Maria Stella, Sandra Di Gregorio, Elena Tirrò, et al.. (2023). Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports. SHILAP Revista de lepidopterología. 15(2). 317–324. 1 indexed citations
2.
Broggi, Giuseppe, Elena Tirrò, Antonietta Arcella, et al.. (2022). Cerebellar liponeurocytoma: clinical, histopathological and molecular features of a series of three cases, including one recurrent tumor. Neuropathology. 42(3). 169–180. 1 indexed citations
3.
Romano, Chiara, Sandra Di Gregorio, Maria Stella Pennisi, et al.. (2022). Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis. Molecular Biology Reports. 49(9). 9059–9064. 3 indexed citations
4.
Stella, Stefania, Silvia Rita Vitale, Fabio Stagno, et al.. (2022). Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. Diagnostics. 12(5). 1051–1051. 3 indexed citations
5.
Broggi, Giuseppe, Roberto Altieri, Chiara Romano, et al.. (2022). Glioblastoma, IDH-Wild Type With FGFR3-TACC3 Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature Review. Frontiers in Neurology. 13. 823015–823015. 12 indexed citations
6.
Tirrò, Elena, Michele Massimino, Giuseppe Broggi, et al.. (2022). A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications. Frontiers in Oncology. 12. 861078–861078. 23 indexed citations
7.
Tirrò, Elena, Federica Martorana, Nicola Inzerilli, et al.. (2022). Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience. Pathology - Research and Practice. 232. 153820–153820. 6 indexed citations
8.
Sapuppo, Giulia, Federica Martorana, Elena Tirrò, et al.. (2022). Orbital metastasis from thyroid cancer: a case report and review of the literature. Annals of Palliative Medicine. 11(10). 3346–3355. 1 indexed citations
9.
Broggi, Giuseppe, Lucia Salvatorelli, Davide Barbagallo, et al.. (2021). Diagnostic Utility of the Immunohistochemical Expression of Serine and Arginine Rich Splicing Factor 1 (SRSF1) in the Differential Diagnosis of Adult Gliomas. Cancers. 13(9). 2086–2086. 35 indexed citations
10.
Stella, Stefania, Silvia Rita Vitale, Michele Massimino, et al.. (2021). A Novel System for Semiautomatic Sample Processing in Chronic Myeloid Leukaemia: Increasing Throughput without Impacting on Molecular Monitoring at Time of SARS-CoV-2 Pandemic. Diagnostics. 11(8). 1502–1502. 1 indexed citations
11.
Massimino, Michele, Paolo Vigneri, Stefania Stella, et al.. (2021). Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic Cells. Journal of Clinical Medicine. 10(23). 5606–5606. 11 indexed citations
12.
Tirrò, Elena, Michele Massimino, Chiara Romano, et al.. (2021). Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma. Frontiers in Oncology. 10. 612385–612385. 31 indexed citations
13.
Vitale, Silvia Rita, Federica Martorana, Stefania Stella, et al.. (2021). PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance. Critical Reviews in Oncology/Hematology. 162. 103334–103334. 30 indexed citations
14.
Stella, Stefania, Elena Tirrò, Michele Massimino, et al.. (2019). Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose Imatinib. In Vivo. 33(5). 1593–1598. 6 indexed citations
15.
Tirrò, Elena, Michele Massimino, Stefania Stella, et al.. (2019). Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22). Anticancer Research. 39(7). 3893–3899. 12 indexed citations
16.
Tirrò, Elena, Stefania Stella, Michele Massimino, et al.. (2019). Colony-Forming Cell Assay Detecting the Co-Expression of <b><i>JAK2</i></b><sup>V617F</sup> and <b><i>BCR-ABL1</i></b> in the Same Clone: A Case Report. Acta Haematologica. 141(4). 261–267. 9 indexed citations
17.
Stella, Stefania, Michele Massimino, Elena Tirrò, et al.. (2018). B-ALL Relapses After Autologous Stem Cell Transplantation Associated With a Shift from e1a2 to e14a2 BCR-ABL Transcripts: A Case Report. Anticancer Research. 39(1). 431–435. 11 indexed citations
18.
Massimino, Michele, Maria Mesuraca, Fabio Stagno, et al.. (2014). IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation. Carcinogenesis. 35(5). 1132–1143. 25 indexed citations
19.
Stella, Stefania, Elena Tirrò, Enrico Conte, et al.. (2013). Suppression of Survivin Induced by a BCR-ABL/JAK2/STAT3 Pathway Sensitizes Imatinib-Resistant CML Cells to Different Cytotoxic Drugs. Molecular Cancer Therapeutics. 12(6). 1085–1098. 51 indexed citations
20.
Bellodi, Cristian, Mattia Ronchetti, Sara Galavotti, et al.. (2013). Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells (vol 119, pg 1109, 2009). UCL Discovery (University College London).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026